NASDAQ:SRNE Investor Notice: Lawsuit Alleges Securities Laws Violations by Sorrento Therapeutics, Inc.

San Diego, CA -- (SBWIRE) -- 06/09/2020 -- An investor, who purchased shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE), filed a lawsuit over alleged violations of Federal Securities Laws by Sorrento Therapeutics, Inc. in connection with certain allegedly false and misleading statements.